Inmalab Cia. Ltda.

RUC 1791435761001 · Pichincha

This company is no longer in the current registry of the Superintendencia de Compañías. Its file is kept here as historical record, with the financial statements it filed through 2009.

Registry data

RUC: 1791435761001
Legal name: INMALAB CIA. LTDA.
Company type: Limited liability company (Cía. Ltda.)
Start of activities (SRI): June 18, 1999
Economic activity: Manufacture of active medicinal substances used for their pharmacological properties in the manufacture of medicaments: antibiotics, basic vitamins, salicylic and acetylsalicylic acids, etc.; processing of blood; manufacture of medicaments: antisera and other blood fractions, chemically pure sugars, endocrine products and extracts, vaccines, including homeopathic preparations; manufacture and processing of glands and glandular extracts; manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments; manufacture of medical diagnostic preparations, including pregnancy tests, etc.
ISIC code: C2100.01
Last year with filed statements: 2009
Location: Pichincha

Financial statements

Current ratio: 0.53
Debt ratio: 131.6%
Net margin: 3.7%
Revenue vs 2008: +105.1%

Revenue by year 2000 → 2009 · −27.5%

$55.5 k

$87.0 k

$40.2 k

2000 2001 2003 2006 2007 2008 2009

Net result by year 2000 → 2009 · +0.1%

$2.3 k

−$4.9 k

$1.5 k

2000 2001 2003 2006 2007 2008 2009

Employees by year 2008 → 2009 · +0.0%

2008 2009

The income statement · 2009

Revenue $40,225
Cost of sales $24,385
Expenses $13,803
Net result $1,507

Financial statements filed with the Superintendencia de Compañías, year by year
Year	Revenue	Net result	Assets	Equity	Employees
2009	$40,225	$1,507	$7,532	−$2,381	1
2008	$19,609	$859	$4,518	−$4,419	1
2007	$56,868	−$1,267	$4,754	−$5,739	—
2006	$37,977	−$4,872	$6,912	$3,653	—
2003	$54,516	$802	$22,636	$6,731	—
2001	$87,010	$2,281	$12,087	$5,438	—
2000	$55,508	$1,506	$8,147	$2,499	—

In 2009 it recorded revenue of $40,225 and a net result of $1,507, a margin of 3.7%.

Its 2009 revenue exceeds that of 28.3% of the 35,263 companies in the country that recorded sales that year. In Pichincha, it exceeds 22.9% of the 12,708 on record.

Within its activity (ISIC code C2100.01, 90 companies with sales), its revenue exceeds that of 17.8%; the trade’s typical margin was 2.4%.

Values in US dollars, as filed with the Superintendencia de Compañías, Ecuador’s corporate regulator.

Tax status (SRI)

updated September 3, 2026

RUC status: Suspended · Depuracion

Phantom taxpayer: No
Nonexistent transactions: No

Tax regime: General regime The set of rules under which it files its taxes
Required to keep accounting books: Yes
Withholding agent: No When paying third parties, it withholds taxes and remits them to the SRI
Special taxpayer: No Designated by the SRI for its size, with additional filing obligations
Start of activities: June 18, 1999
Cessation of activities: March 12, 2012

Establishments · 1 registered, 0 open

HEAD OFFICE Pichincha / Quito / Quito Distrito Metropolitano / Rio Coca 1936 y Isla Floreana Closed

Tax status according to the public records of the SRI (Servicio de Rentas Internas, the national tax authority). The risk designations are the SRI’s, not a rating by this site: phantom taxpayer means the SRI considers the company to have no real activity at its declared address, and nonexistent transactions means it invoiced operations the SRI determined never took place.

Activity classification (ISIC)

Frequently asked questions

What is the RUC of Inmalab Cia. Ltda.?

The RUC (taxpayer registration number) of INMALAB CIA. LTDA. is 1791435761001, according to Ecuador’s public corporate registry.

Is Inmalab Cia. Ltda. active?

No. Its legal status in the registry is Fuera del Registro Vigente.

What does Inmalab Cia. Ltda. do?

Its registered economic activity (ISIC C2100.01) is: Manufacture of active medicinal substances used for their pharmacological properties in the manufacture of medicaments: antibiotics, basic vitamins, salicylic and acetylsalicylic acids, etc.; processing of blood; manufacture of medicaments: antisera and other blood fractions, chemically pure sugars, endocrine products and extracts, vaccines, including homeopathic preparations; manufacture and processing of glands and glandular extracts; manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments; manufacture of medical diagnostic preparations, including pregnancy tests, etc.

Related companies

Corporate information from official public records of Ecuador · where this data comes from